What is the appropriate dose and administration route for rabies vaccination in children?

Rabies Vaccination in Children: Dose and Route

Children receive the same 1.0 mL vaccine dose as adults, administered intramuscularly in the deltoid for older children or the anterolateral thigh for younger children, never in the gluteal area. 1

Postexposure Prophylaxis (PEP) Dosing

Previously Unvaccinated Children

• Vaccine dose: 1.0 mL per injection (same volume as adults)
• Schedule: 4 doses on days 0,3,7, and 14 1
• Route: Intramuscular (IM) only
• Site selection:
  • Deltoid muscle for older children
  • Anterolateral aspect of thigh for younger children
  • Never use gluteal area - subcutaneous fat interferes with immune response and may cause vaccine failure 2

Human Rabies Immune Globulin (HRIG)

• Dose: 20 IU/kg body weight on day 0 1
• Administration: Infiltrate full dose around/into wounds if anatomically feasible; inject remaining volume IM at site distant from vaccine
• Critical: Do not administer HRIG in same syringe or same anatomic site as vaccine 1

Previously Vaccinated Children

• Vaccine only: 2 doses of 1.0 mL on days 0 and 3 1
• No HRIG needed 1

Special Considerations

Immunosuppressed Children

• Require 5 doses instead of 4: days 0,3,7,14, and 28 1
• Consider serologic testing to verify adequate response 2

Pre-exposure Prophylaxis

• Dose: Three 1.0 mL injections (same as adults) 2
• Schedule: Days 0,7, and 21 or 28 2
• Route: IM in deltoid (older children) or anterolateral thigh (younger children) 2

Critical Pitfalls to Avoid

1. Never reduce vaccine volume for children - they require the full 1.0 mL adult dose 1
2. Avoid gluteal injection - associated with vaccine failure due to fat interference with immune response 2
3. Do not delay HRIG - must be given on day 0, can be administered up to day 7 if initially missed 1
4. Never co-administer HRIG and vaccine in same syringe or site - RIG may suppress active antibody production 1

Evidence Quality

The ACIP guidelines 1 explicitly state these regimens are "applicable for persons in all age groups, including children" and emphasize that "children should receive the same vaccine dose (i.e., vaccine volume) as recommended for adults." This is reinforced by FDA labeling 2 which confirms identical dosing across age groups with only anatomic site variation based on body mass.

Research supports long-term efficacy of these regimens in children 3, 4, with studies demonstrating adequate immune responses maintained for years after vaccination when proper dosing and routes are followed.